Medicare coverage for cardiac rehabilitation for some people with heart failure was expanded almost a decade ago, and medical guidelines recommend it. Yet those who could benefit often don't get it, a new study finds.
Jul 13, 2023
0
0
People who are regular cannabis users are at an increased risk of experiencing complications before, during, and after surgery, according to a study by researchers with UTHealth Houston published today in JAMA Surgery.
Jul 5, 2023
0
2
New research out of VCU Massey Cancer Center indicates that many adolescent and young adult kidney cancer survivors are at a significantly elevated risk for heart issues.
Jul 5, 2023
0
2
New study shows that long-term disinvestment in health and wealth resources in historically redlined neighborhoods likely contributes to a disproportionate rate of kidney failure among Black adults today.
Jun 29, 2023
0
1
What happens after a first-time hospitalization for heart failure? While there are guidelines on optimal treatment of patients with heart failure, researchers at Baylor College of Medicine have found that if those guidelines ...
Jun 26, 2023
0
2
The cause of a common kidney disease likely lies outside the kidney, according to a new study led by Columbia University researchers. The study, which uncovered 16 new locations in the genome linked to immunoglobulin A (IgA) ...
Jun 23, 2023
0
33
Peer support groups may be a patient-centered strategy to provide emotional support and camaraderie for undocumented immigrants with kidney failure, according to a study published online June 21 in JAMA Network Open.
Jun 22, 2023
0
1
Mortality in patients with kidney failure has been found to be 23% lower among those treated with high dose hemodiafiltration compared to those treated with high flux hemodialysis, according to new research from the CONVINCE ...
Jun 16, 2023
0
78
The gold standard test for predicting the onset of diabetic kidney disease is the albuminuria test. However, detecting albuminuria alone has limited sensitivity and specificity in end-stage renal failure with a decreased ...
Jun 13, 2023
0
5
Swiss pharmaceutical giant Novartis said Monday that it had reached a deal to buy US kidney treatment developer Chinook Therapeutics for up to $3.5 billion.
Jun 12, 2023
0
2
